People who LIKE movies have a favorite. People who LOVE movies couldn't possibly choose.” ? Nicole Yatsonsky
Today we look at a small developmental firm with multiple shots on goal but that has largely destroyed shareholder value since coming public. The shares seem to have stabilized in 2019 and a Busted IPO Forum member requested a deeper dive on this small cap concern. Our investment analysis follows in the paragraphs below.
Company Overview:
Sienna Biopharmaceuticals (SNNA) IPO’d in 2017 and is a California-based clinical-stage biopharmaceutical company focused on developing and advancing targeted,